Drug Trial Radar · NCT07931547
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
450
Planned (sponsor's estimate)
Start
Nov 10, 2026
Primary completion
Jul 31, 2028
Study completion Sep 25, 2028
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is testing zenagamtide in participants with type 2 diabetes and chronic kidney disease. The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have type 2 diabetes. Participants will either get zenagamtide or placebo. Which treatment participants get is decided by chance. Zenagamtide is a new medicine that doctors cannot prescribe yet, but it has been tested in humans before.
Conditions
- Type 2 Diabetes
- Chronic Kidney Disease
Interventions
PlaceboOther
Placebo matched to zenagamtide will be administered subcutaneously once weekly.
ZenagamtideDrug
Zenagamtide will be administered subcutaneously once weekly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in glycated haemoglobin (HbA1c)Time frame: From baseline (week 0) to week 52
Locations
125 sites in 10 countries. Site status is shown where the registry gives one.
Scripps Whittier Diabetes Inst
La Jolla, California
First Valley Medical Group
Lancaster, California
Headlands Research CTR Lincoln
Lincoln, California
North America Research Institute
San Dimas, California
Northeast Research Institute
Fleming Island, Florida
Encore Medical Research LLC
Hollywood, Florida
My Preferred Research
Miami, Florida
Adult Medicine of Lake County, Inc
Mt. Dora, Florida
West Orange Endocrinology
Ocoee, Florida
Florida Inst For Clin Res LLC
Orlando, Florida
Care Access
Tamarac, Florida
Encore Medical Research of Weston
Weston, Florida
Palm Research Center Inc-Vegas
Las Vegas, Nevada
DM Clinical
Brooklyn, New York
University of North Carolina Chapel Hill
Chapel Hill, North Carolina
Carteret Medical Group
Morehead City, North Carolina
Spartanburg Medical Research
Spartanburg, South Carolina
Holston Medical Group Pc
Bristol, Tennessee
Southeast Renal Research Institute
Chattanooga, Tennessee
Clinical Research Associates
Nashville, Tennessee
Victorium Clinical Research
Houston, Texas
Prolato Clinical Research Cntr
Houston, Texas
Southwest Clinical Trials
Houston, Texas
Medical Colleagues-Texas LLP
Katy, Texas
Northeast Clinical Research of San Antonio
San Antonio, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
Hospital de Clínicas de Porto Alegre_Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Núcleo de Pesquisa Clínica do Rio Grande do Sul Ltda.
Porto Alegre, Rio Grande do Sul, Brazil
Instituto de Pesquisa Clínica de Campinas
Campinas, São Paulo, Brazil
CPQuali Pesquisa Clínica Ltda
São Paulo, São Paulo, Brazil
The Second People's Hospital of Hefei-Endocrinology
Hefei, Anhui, China
Chongqing University Three Gorges Hospital-Endocrinology
Chongqing, Chongqing Municipality, China
Huizhou Central People's Hospital-Endocrinology
Huizhou, Guangdong, China
The Second People's Hospital of Shenzhen-Endocrinology
Shenzhen, Guangdong, China
Hengshui People's Hospital (Harrison International Peace Hospital)-Endocrinology
Hengshui, Hebei, China
The Second Hospital of Hebei Medical University-Endocrinology
Shijiazhuang, Hebei, China
Huaihe Hospital of Henan University-Endocrinology
Kaifeng, Henan, China
Luoyang First People's Hospital-Endocrinology
Luoyang, Henan, China
The First Affiliated Hospital of Henan University of Science and Technology-Endocrinology
Luoyang, Henan, China
The First Affiliated Hospital of Nanyang Medical College-Endocrinology
Nanyang, Henan, China
Showing 40 of 125 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.